Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
[3] While human trials remain limited, these findings raise interest in possible therapeutic applications
Novel delivery system using thermodynamically stable ionic liquid microemulsions to improve topical delivery and stability of copper tripeptides
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
B12 Frequency The frequency of treatment also varies
No pharmacy visits
You are over the age of 50 (when stomach acid naturally declines)
US$ 21.67
US$ 26.77
US$ 20.55
US$ 21.85
US$ 20.66
